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ABSTRACT
Aim: The aim of the study was to evaluate the Inflammatory Bowel Disorder activity of 
EASG&CHSG extracts of  Simarouba glauca on Experimentally induced Inflammatory  Bowel  
Disease in wistar rats. Methods: The levels of phytochemicals were quantified and HPTLC 
study was conducted using β-sitosterol as reference. In vitro antioxidant property of EASG & 
CHSG was evaluated using DPPH and ABTS assay. in vitro anti activity of EASG & CHSG was 
investigated against MTT assay on caco2 cell lines. Evaluation of IBD was done in wistar rats.
Rats were treated with indomethacin (7.5mg/kg,s.c ,6% glacial acetic acid(0.1ml,intrarectal) for 
3days after 14 days pretreatment with extract and standard drug (prednisolone 10mg/kg). The 
MPO Level, macroscopic features scoring, body weight analysis and microscopic 
(histopathological study was carried out and evaluated. Antioxidant potential of intestinal tissue 
was determined by measuring activities of Superoxide Dismutase, Catalase, Glutathione 
peroxidase, Lipid per oxidation and reduced Glutathione. Results: EASG & CHSG possessed
considerable amount of phytoconstituents such as flavonoid, phenols and β-sitosterol; and also 
significantly scavenged the free radicals making it a potent antioxidant. The results of 
macroscopic scoring and MPO level activity suggest that EASG & CHSG at 400mg/kg
significantly (p < 0.001) reduced the inflammation in IBD induced animals in both the models. 
In In vitro cytotoxicity study , a significant reduction in cell damage was observed when caco2 
cells were pretreated with EASG and CHSG extracts when compared to control. EASG & CHSG 
at 400mg/kg significantly reduced lipid per oxidation and increased the Superoxide 
Dismutase(SOD), Catalase(CAT) and Glutathione peroxidase(GPx).Reduced Glutathione(GSH)
levels and produced significant antioxidantactivity. Conclusion: Attributing to the potent 
antioxidant and anti-inflammatory activity, we could conclude that the EASG & CHSG of 
Simarouba glauca showed significant anti- inflammatory activity due to presence of β-sitosterol 
and antioxidants such as phenols and flavonoids.
Keywords: Ethylacetate extract of Simarouba glauca (EASG) & Chloroform extract of 
Simarouba glauca (CHSG), Inflammatory Bowel Disease (IBD), Myeloperoxidase(MPO)
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3.1. MATERIALS USED FOR THE STUDY
Table 1: List of instruments
Sl.No
               
          Instruments Manufacture
1 Analytical weighing balance Shimadzu
2 Cooling centrifuge Remi
3 Deep freezer (-800 C) Remi
12 Digital Vernier Caliper Absolute digimatic
11 Electric water bath Technico
4 Homogenizer Remi
5 Hot air oven Narang Scientific works
6 HPTLC Camag
7 pH meter Eutech
10 Rotary evaporator IKA RV10
8 Ultra sonicator Soltec
9 UV Spectrophotometer PharmaspecUV-
1700,Shimadzu
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Table 2: List of chemicals
SL.No              Chemical     Manufacturer
1 2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic 
acid)Diammonium salt(ABTS)
Himedia
2 5,5-dithiobis (2-nitro benzoic acid) DTNB Himedia
3 Ascorbic acid SISCO
4 Bovine serum albumin(BSA) SD- Fine chem.
5 1,1-diphenyl-2-picrylhydrazyl(DPPH) Sigma Aldrich
6 Folin-Ciocalteu reagent SD-Fine chem.
7 Gallic acid Sigma Aldrich
8 Glutathione reduced Himedia
9 Sodium azide Himedia
10 Thiobarbituric acid(TBA) Himedia
11 Trichloric acetic acid(TCA) Himedia
12 Quercetin Himedia
13 Indomethacin Microlabs
14 6% glacial acetic acid Himedia
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3.2.METHODS
3.2.1. PLANT COLLECTION AND AUTHENTICATION
Simarouba glauca was collected from Alapuzha district,Kerela and authenticated from Botanical 
survey of India (BSI) Southern circle,Coimbatore Tamil nadu.The authentication  certificate 
number is No.BSI/SRC/5/23/2016/tech/604 .Soon after collection ,the leaves were dried in the 
shade and crushed to coarse powder for extraction.(41)(42).
3.2.2. EXTRACTION OF THE PLANT MATERIAL
The leaves were first treated  with petroleum ether , the defatted material was then extracted with 
ethyl acetate and chloroform using soxhlet apparatus. After extraction the solvent was evaporated 
by using rotary evaporator and dried at room temperature to give viscous mass. The crude extracts 
were weighed and stored at 40C before analysis.
3.2.3. QUALITATIVE PHYTOCHEMICAL ANALYSIS OF CHSG AND EASG.
Preparation of test sample
A small quantity of extract was dissolved in 5ml of distilled water and then filtered.The filtrate 
was tested to detect the presence of different phytochemical constituents in the sample.
3.2.3.1. TEST FOR CARBOHYDRATES
 Molisch’s test:
To 2-3ml of filtrate,few drops of Molisch’s reagent was added.Then concentrated sulphuric acid
was added along the sides of test tube.Appearance of violet colour ring at the junction of two 
liquids infers the presence of carbohydrates.
 Fehling’s test
1ml of Fehling’s-A(copper sulphate in distilled water) was mixed with 1ml Fehling’s-
B(Potassium tartarate and sodium hydroxide in distilled water) Solutions in a test tube and was 
boiled for one minute. 1ml of filtrate was added and heated gently.Formation of brick red 
precipitate indicates the presence of reducing sugars.
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 Benedict’s test
Equal volume of filtrate and Benedict’s reagent (alkaline solution containing cupric citrate 
complex) was mixed and heated in boiling water bath for 5min.Formation of reddish brown 
precipitate infers the presence of reducing sugars.
3.2.3.2. TEST FOR ALKALOIDS
Small amount of extract was mixed with few ml of dilute.hydrochloric acid.shaked well and 
filtered.The filtrate was used to perform the following tests:
 Dragendroff’s test
To 2-3ml of filtrate, few drops of dragendroff’s reagent(potassium bismuth iodide solution)
was added. Formation of orange red precipitate indicates the presence of alkaloids
 Mayer’s test
To 2-3ml of filtrate, few drops of Mayer’s reagent (potassium mercuric iodide solution) was 
added.Cream (dull white) precipitate are formed.
 Wagner’s test
To 2-3ml of filtrate, few drops of Wagner’s reagent (solution of iodine in potassium iodide)
was added. Reddish brown precipitate was obtained.
 Hager’s test
To 2-3mlof filtrate, few drops of Hager’s reagent was added. Yellow precipitate was obtained.
3.2.3.3. TEST FOR TRITERPENOID
 Libermann-Burchard test:
      To the extract few drops of acetic anhydride was added, followed by few drops of    
concentrated sulphuric acid. A brown ring formed at the junction of two layers and the upper 
layer turned green colour, infers the presence of phytosterols and formation of deep red colour 
indicates the presence of triterpenoid.
 Salkowski test:
         To small quantity of the extract chloroform and few drops of concentrated sulphuric acid 
was added and allowed to stand for few minutes. Yellow colour at the lower layer indicates the 
presence of triterpenoids.
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3.2.3.4. TEST FOR GLYCOSIDES
 Legal’s test
To the extract, 1ml of pyridine and 1ml of sodium nitroprusside was added. Pink to red colour 
appeared.
 Keller-Killiani test
To 2ml extract, glacial acetic acid, trace quantity of ferric chloride was added and 2 to 3 drops of 
concentrated sulphuric acid was added. Reddish brown colour appeared at the junction of two 
liquid indicates the presence of cardiac glycosides.
 Baljet test:
To 2ml of extract sodium picrate solution was added. Yellow to orange colour formation indicates 
the presence of glycosides.
3.2.3.5. TEST FOR STEROIDS AND STEROLS
 Liebermann- Burchard reaction
2ml of extract was mixed with chloroform. 1-2ml of acetic anhydride and 2 drops of concentrated 
sulphuric acid was added along the sides of the test tube. The solution became red, then blue and 
finally bluish green colour.
 Salkowski reaction
To  2ml of extract, 2ml chloroform and 2ml concentrated sulphuric acid was added. Shaken well. 
Chloroform layer appeared  red and acid layer showed greenish yellow fluorescence.
3.2.3.6. TEST FOR PHENOLS
 Ferric chloride test
To 1ml of the alcoholic solution of the extract, 2ml of distilled water followed
by few drops of 10% ferric chloride was added. Formation of blue or green colour indicates the
presence of phenols.
 Lead acetate test
1ml of alcoholic solution of extract was diluted with 5ml distilled water and to this 
few drops of 1% aqueous solution of lead acetate was added. A yellow colour precipitate was
formed.
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3.2.3.7. TEST FOR TANNINS
 Lead acetate test
To 5ml of aqueous extract, few drops of lead acetate was added. A yellow or red colour
precipitate was formed.
3.2.3.8. TEST FOR SAPONINS
 Foam Test:
1 ml of test sample was diluted with 20 ml of distilled water and shaked it in a
graduated cylinder for 3 minutes. Foam of 1 cm after 10 min indicates the presence
of saponins.
 Froth test:
To 5 ml of test sample few drops of sodium bicarbonate was added.  The mixture
Was shaked vigorously and kept it for 3 minutes. A honey comb like froth formation indicates 
the presence of saponins.
3.2.3.8. TEST FOR FLAVONOIDS
 Zinc hydrochloride reduction test
The extract with mixture of zinc dust and concentrated hydrochloric acid was treated.Formation 
of red colour indicates the presence of flavonoids.
 Alkaline reagent test
To the extract, few drops of sodium hydroxide solution was added. Formation of an intense
yellow colour, which turns to colourless on addition of few drops of dilute hydrochloric acid, 
indicates the presence of flavonoids.
3.2.3.9. TEST FOR PROTEINS AND AMINO ACIDS
 Biuret test
To 3ml of test solution 4% sodium hydroxide was added and few drops of 1% copper sulphate 
solution. Formation of violet colour indicates the presence of proteins.
 Ninhydrin test
3ml of test solution and 3drops of 5% Ninhydrin solution was heated in boiling water bath for 
10min. Formation of purple or bluish colour indicates the presence of free amino acids.(43)(44).
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3.2.4. HIGH PERFORMANCE THIN-LAYER CHROMATOGRAPHIC (HPTLC) 
METHOD FOR ESTIMATION OF STEROIDS.
High performance thin layer chromatography (HPTLC) is a suitable quality assessment tool for 
the evaluation of herbal medicines and natural drug. Additionally, numerous samples can be run 
in a single analysis thereby it will reduce the analytical time. With HPTLC, the same analysis can 
be view that single and different wavelength of light; thereby providing a more complete profile 
of the plant and it is typically observed with more specific types of analysis.
Experimental conditions
 Stationary phase   : Aluminium plates precoated with Silica Gel 60F254 (10cm×10cm×0.2 
mm thickness)
 Mobile phase                :Acetone:hexane(3:9)
 Sample for HPTLC       : CHSG,EASG and standard steroid solution
 Sample application       : Camag Linomat 5
 Chamber type               : Twin trough Chamber 10× 10 cm
 Chamber saturation        : 5 min
 Development time          : 30 min
 Development distance   : 7 cm
 Detection                        : Camag Scanner 3
 Data system                    : win CATS Planar Chromatography Manager.
Instrumental Parameters
 Number of track            : 9
 Band length                   : 6.0 mm
 Application position      : 10 mm
 Solvent front position     : 80.0 mm
 Solvent volume              :10 ml
 Position of first track    : 10 mm
 Distance between tracks  : 10.0 mm
 Scan start position Y     : 5.0 mm
 Scan end position             : 75.0 mm
 Slit dimension                 : 6.00 × 0.45 mm, Micro
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 Optimized optical system  : light
 Scanning speed                  : 20 mm/sec
 Data resolution                  : 100 μm/ step
Measurement table:
 Wavelength                   : 366 nm
 Lamp                              : D2 & W
 Measurement type           : Remission
 Measurement mode          : Absorption
 Optical filter                    : Second order
 Detector mode                : Automatic
            Preparation of standard
A stock solution of β-sitosterol (1mg/ml) was prepared in methanol. Different volumes of 
stock solution 1μl,3μl,5μl,7μl,10μ,12μl,15μl were spotted on TLC plate to obtain 
concentration of 0.001,0.003,0.005,0.007,0.01,0.012,0.015 mg/spot of β-sitosterol.
Preparation of test sample
Weighed accurately 1g  of  both CHSG and EASG and dissolved separately in 10 ml of 
chloroform and ethylacetate respectively. Each sample was filtered using WhatmannNo.1 
filter paper.10μl of both extracts were spotted on TLC plate.
Principle: The fundamental mechanisms are the partitioning of the moving compounds 
between two liquid phases and also their being reversely bound on the surface of the 
adsorbent. Adsorption denotes the enrichment of a gaseous or dissolved material at a 
phase boundary (Surface of a solid). The effects of adsorption are particularly marked 
when the interface was large. The separation achieved in absorption chromatography is 
strongly dependent upon the surface of the powdered adsorbent.
       When, a mixture of compounds is spotted on a HPTLC plate, the compound which 
was soluble and not strongly adsorbed moves up fast along with the solvent. Those which 
are not so soluble are more strongly absorbed moves up less, readily leading to the 
separation of the compound. The behavior of the compound is dependent upon both 
adsorbent and solvent.(45)
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          Procedure:
  The samples; β-sitosterol 1μl,3μl,5μl,7μl,10μ,12μl,15μl and CHSG and EASG 10μl and 10μl 
were spotted in form of bands with a Camag microlite syringe on pre-coated Silica Gel glass plate 
60F254 (10×10 cm with 0.2 mm thickness ) using a Camag Linomat 5 applicator. The plates were 
pre-washed with methanol and activated at 60oC for 10 min prior to chromatography. The sample 
loaded plate was kept in TLC twin trough developing chamber after chamber saturation with 
respective mobile phase. The optimized chamber saturation time for mobile phase was 5 min at 
room temperature. Linear ascending development was carried out and the plate was developed in 
the respective mobile phase up to 7 cm. The developed plate was then dried by hot air oven for 
the development of bands . The dried plate was observed under UV light at 254nm and 366nm 
and photo documentation was done. Densitometric scanning was performed on Camag TLC 
scanner 3 in the absorbance mode at 366nm. The percentage of active ingredient(β-sitosterol) 
present in the SG leaf extract was compared with the standard.(45)(46)(47)
3.2.5. QUANTIFICATION OF TOTAL PHENOLS AND FLAVONOIDS
3.2.5.1. ESTIMATION OF TOTAL PHENOLS
Reagents
 Folin-Ciocalteu’s reagent
 20% sodium carbonate
Procedure
The total phenols of the EASG and CHSG were determined by the Folin-Ciocalteau assay
method. An aliquot (1000μl) of extract (1mg/ml) or standard solution of Gallic acid (10, 20, 40,
60, 80, 100μg/ml) were mixed with 50μl of Folin-ciocalteau reagent and 860μl of distilled water 
and incubated for 5min at room temperature. Then100μl of  20% sodium carbonate and 890μl of 
distilled water were added to the above mixture and kept in dark for 30 min to complete the 
reaction. After incubation, absorbance of the mixture was measured against blank at 725nm. 
Distilled water was used as reagent blank. The calibration curve of Gallic acid was prepared. All 
the tests were performed in triplicate in order to get mean the values. The total phenol content was 
expressed as milligrams of Gallic acid equivalents (GAE) per gram of extract.(48)
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3.2.5.2. ESTIMATION OF TOTAL FLAVONOIDS
Reagents
 Methanol
 10% aluminium chloride
 1M Potassium acetate
Procedure
The total flavonoid content of the EASG and CHSG was determined by using Aluminium
chloride colorimetric method. An aliquot (1ml) of extract (1mg/ml) or standardsolutions of 
Quercetin (10, 20, 40, 60, 80, 100μg/ml)in methanol were separately mixed with 1ml of 
methanol,0.1ml of 10% aluminium chloride, 0.1ml of 1M potassium acetate and 2.8ml of distilled 
water. Shaken well and incubated at room temperature for 30 min. After incubation, absorbance 
of the reaction mixture wasmeasured at 415nm. Methanol (2ml) was used as reagent blank. To 
substitute 10%aluminium chloride, 100μl of distilled water was added to the blank. The 
calibration curve of Quercetin was prepared. All the tests were performed in triplicate in order to 
get the mean values. The total flavonoid content was expressed as milligrams of Quercetin 
equivalents per gram of extract.(48)
3.2.6. INVITRO-ANTIOXIDANT STUDIES OF EASG & CHSG.
3.2.6.1. DPPH FREE RADICAL SCAVENGING ASSAY
Principle
The molecule of 1, 1-diphenyl-2-picrylhydrazyl (α, α-diphenyl-β-picrylhydrazyl;
DPPH) is characterized as a stable free radical by virtue of the delocalization of the
spare electron over the molecule as a whole, so that the molecules do not dimerise,
as would be the case with most other free radicals. The delocalization also gives rise to the deep 
violet colour, characterized by an absorption band in ethanol/methanol solution centred at about 
520 nm. When a solution of DPPH is mixed with that of a substance that can donate a hydrogen 
atom, then this gives rise to the reduced form with the loss of this violet colour (although there 
would be expected to be a residual pale yellow colour from the picryl group still present). 
Representing the DPPH radical by Z• and the donor molecule by AH, the primary reaction is
Z• + AH = ZH+ A•.(49)
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Procedure
The antioxidant activity of the extract was measured in terms of hydrogen donating
or radical scavenging ability using the stable DPPH radical (Blois method).0.3mM
solution of DPPH in methanol was prepared and 1ml of this solution was added to
1ml of various concentrations of sample and the reference compound (10, 20, 30, 40 and 50 
μg/ml), were shaken vigorously and left to stand in the dark at room
temperature for 30 min and then absorbance was measured at 517 nm against a
blank. Reference compound used here was ascorbic acid. A control reaction was
carried out without the test sample. All the tests were performed in triplicate in order to get the 
mean values. The percentage of inhibition was calculated by comparing the absorbance values of 
the control and test samples. Antiradical activity was expressed as percentage inhibition (I %) and 
calculated using the following equation.(48).
Percentage inhibition (I %) = (Abs control- Abs sample /Abs control) X 100
Different sample concentrations were used in order to obtain calibration curves and
to calculate the EC50 values. (EC50 - concentration required to obtain a 50% radical scavenging 
activity).
3.2.6.2.ABTS RADICAL CATION ASSAY
Principle
ABTS decolourization assay is an inhibition method. The peroxidase substrate 2, 2’-azinobis (3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS), forms a relatively stable radical (ABTS+) upon 
one electron oxidation. This assay is based on the scavenging of light by ABTS radicals. An 
antioxidant with an ability to donate a hydrogen atom will quench the stable free radical and 
inhibits the absorption of the radical cation which has characteristic long-wavelength absorption 
spectrum showing maxima at 660,734, and 820nm.The relatively stable ABTS radical has a green 
colour and is quantified spectrometrically at 734nm.(50)
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Procedure
ABTS radical scavenging activity of the extract was measured by Rice-Evans
method. ABTS was dissolved in water to a 7mM concentration. ABTS radical cation (ABTS+) 
was produced by reacting ABTS stock solution with 2.45mM potassium persulfate and allowing 
the mixture to stand in the dark at room temperature for 12-16 h before use. The radical was 
stable in this form for more than 2 days when stored in the dark at room temperature. For the 
study, ABTS solution was diluted with phosphate buffer saline pH 7.4 (PBS) to an absorbance of 
0.70 (± 0.02) at 734nm and equilibrated at 300c. After addition of 2ml of diluted ABTS+ solution 
to 20μl of various concentrations of sample or reference compound (ascorbic acid), the reaction 
mixture was incubated for 6min and then absorbance was measured at 734 nm against a blank. A 
control reaction was carried out without the sample. All the tests were performed in triplicate in 
order to get the mean values. The percentage inhibition of ABTS+ by the sample was calculated 
according to the formula:
Percentage inhibition (I %) = (Abs control- Abs sample /Abs control) X 100
Different sample concentrations were used in order to obtain calibration curves and
to calculate the EC50 values. (EC50 - concentration required to obtain a 50% radical scavenging 
activity).(48)
3.2.7. INVITRO CYTOTOXICITY STUDY OF EASG & CHSG.
Reagents used:
 3-(4,5–dimethyl thiazol–2–yl)–5–diphenyltetrazolium bromide (MTT),
 Fetal Bovine serum (FBS), Phosphate Buffered Saline (PBS),
 Modified Eagle’s Medium (MEM) and Trypsin( from Sigma Aldrich Co, St Louis, USA).
 EDTA.
 Glucose and antibiotics (from Hi-Media Laboratories Ltd., Mumbai)
 Dimethyl Sulfoxide (DMSO) and Propanol (from E.Merck Ltd., Mumbai, India).
Cell lines and Culture medium
CaCO2 cell line was selected as an invitro cell line(51)(52) and was procured from National 
Centre for Cell Sciences (NCCS), Pune, India. Stock cells were cultured in MEM supplemented 
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with 10% inactivated Fetal Bovine Serum (FBS), penicillin (100 IU/ml), streptomycin (100 
g/ml) and amphotericin B (5 g/ml) in an humidified atmosphere of 5% CO2 at 37C until 
confluent. The cells were dissociated with Trypsin solution (0.2% trypsin, 0.02% EDTA in PBS). 
The stock cultures were grown in 25 cm2 culture flasks and all experiments were carried out in 96 
microtitre plates (Tarsons India Pvt. Ltd., Kolkata, India).
Preparation of Test Solutions
For Cytotoxicity studies, each weighed test drugs were separately dissolved in distilled DMSO 
and volume was made up with MEM supplemented with 2% inactivated FBS to obtain a stock 
solution of 1mg/ml concentration and sterilized by filtration. Serial two fold dilutions were 
prepared from this for carrying out cytotoxic studies.
Determination of cell viability by MTT Assay
Principle: The ability of the cells to survive a toxic insult has been the basis of most Cytotoxicity 
assays. This assay is based on the assumption that dead cells or their products do not reduce 
tetrazolium. The assay depends both on the number of cells present and on the mitochondrial 
activity per cell. The principle involved is the cleavage of tetrazolium salt 3-(4, 5 dimethyl 
thiazole-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) into a blue coloured product (formazan) 
by mitochondrial enzyme succinate dehydrogenase. The number of cells was found to be 
proportional to the extent of formazan production by the cells used.
Procedure: The monolayer cell culture was trypsinized and the cell count was adjusted to 1.0 x 
105 cells/ml using MEM containing 10% FBS. To each well of the 96 well microtitre plate, 0.1 ml 
of the diluted cell suspension (approximately 10,000 cells) was added. After 24 h, when a partial 
monolayer was formed, the supernatant was flicked off, washed the monolayer once with medium 
and 100 l of different test concentrations of test drugs were added on to the partial monolayer in 
microtitre plates. The plates were then incubated at 37o C for 3 days in 5% CO2 atmosphere, and 
microscopic examination was carried out and observations were noted every 24 h interval. After 
72 h, the drug solutions in the wells were discarded and 50 l of MTT in PBS was added to each 
well. The plates were gently shaken and incubated for 3 h at 37o C in 5% CO2 atmosphere. The 
supernatant was removed and 100 l of propanol was added and the plates were gently shaken to 
solubilize the formed formazan. The absorbance was measured using a microplate reader at a 
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wavelength of 540 nm. The percentage growth inhibition was calculated using the following 
formula and concentration of test drug needed to inhibit cell growth by 50% (CTC50) values is 
generated from the dose-response curves for each cell line.(53)
            Mean OD of individual test group          
PPHARMACOLOGICALHARM
3.2.8.ACUTE TOXICITY STUDY.(35)
Based on previously conducted study of Simarouba glauca,the dose was selected.
3.2.8.1. PHARMACOLOGICAL STUDY
Experimental animal
Male wistar rats of 6-8 weeks old and 160-180 g body weight were obtained from the animal 
house ,KMCH College of pharmacy, Coimbatore. All rats were kept at room temperature and 
allowed to accommodate in standard conditions at 12-hr light and 12-hr dark cycle in the animal 
house. Animals were fed with commercial pellet diet and water ad libitum freely throughout the 
study. The experimental procedure was approved by IAEC (Institutional animal ethical 
committee) of KMCH College of Pharmacy, Coimbatore-48 .Governed by CPCSEA Government 
of India. Proposal number: KMCRET/ M.PHARM/03/2015-16).
3.2.8.2.EVALUATION OF INFLAMMATORY BOWEL DISEASES ACTIVITY OF CHSG 
AND EASG.
PREPARATION OF DRUG SOLUTIONS
Standard drug
Prednisolone was used as a standard drug. The drug was dissolved in normal saline and 
administered  orally using gavage needle at a dose of 10mg/kg daily for 3days.
Preparation of extracts
CHSG and EASG was weighed and dissolved in chloroform and Ethylacetate respectively, and it 
was administered orally to the rats at a dose of 400mg/kg each of CHSG and EASG daily upto 
14days.The normal control group received only normal saline .
% Growth Inhibition =100 – X 100
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3.2.8.2.a. INDOMETHACIN- INDUCED ENTEROCOLITIS.
Principle: Indomethacin, a non-selective COX inhibitor produces enterocolitis .Prolonged use of 
Indomethacin is known to induce enterocolitis with pathological features such as transmutable 
ulcers, wall thickening, adhesions, granulomatous inflammation, crypt abscesses and fibrosis in 
jejunum-ileum region. The features are similar to those found in Crohn’s disease . Multiple 
factors namely hepatobiliary export of glucuronides of Indomethacin down regulation of heat 
shock proteins , endoplasmic reticulum stress , and deficiency of endogenous prostaglandins  have 
been identified to be involved in pathogenesis of Indomethacin induced Entrocolites . Increased 
Oxidative stress, mitochondrial dysfunction and inflammation are found to be prominent factors 
that cause destructive changes.(55)
Table3:EXPERIMENTAL DESIGN FOR INDOMETHACIN-INDUCED 
ENTEROCOLITIS
Animals were divided into 5 groups, each group consists of 6 rats.(54)(31)
                  Group                 Treatment
Group I: normal Rats received only normal saline(1ml,p.o) for 
14 consecutive days
Group II: control Rats received indomethacin(7.5mg/kg,s.c), on 
two consecutive days;
Group III: Standard Rats received prednisolone (10mg/kg,p.o), for 
3days and indomethacin (7.5mg/kg,p.o) for 
2days.
Group IV: CHSG and EASG(400mg/kg) Rats received 14days pretreatment with CHSG 
and EASG and indomethacin (7.5mg/kg,s.c), 
for 3 days
Group V: CHSG and EASG (400mg/kg)
Procedure:
Rats (200-250g) were given indomethacin 7.5mg/kg subsutaneously on two consecutive days. On 
the third day after 24 hours fasting the animals were sacrificed by cervical dislocation and 
dissected open to remove GIT (from stomach to anus). GIT s was flushed gently and cut open.
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     Duedenum,jejunum,ileum,caecum  and colon were scored for inflammation based on their 
macroscopic features.Tissues were fixed in 10% formalin saline and examined 
histopathologically.
  Quantification of inflammation was done using myeloperoxidase assay.(31)(55)(56)
3.2.8.2.b. ACETIC ACID -INDUCED ENTEROCOLITIS IN RATS
Principle:  Intrarectal administration of dilute solution of acetic acid causes non-transmural 
inflammation characterized by increased neutrophil infiltration into the intestinal tissue, massive 
necrosis of mucosal and submucosal layers, vascular dilation, edema and submucosal ulceration 
that are noteworthy features of human colitis . Acetic acid cause damage to distal colon portion, 
The mechanisms by which acetic acid produces inflammation appear to involve the entry of the 
protonated form of the acid into epithelium, where it dissociates to liberate protons within 
intracellular acidification that are  likely accounts for the epithelial injury.(13)
Table 4: EXPERIMENTAL DESIGN FOR ACETIC ACID INDUCED ENTEROCOLITIS
Animals were divided into 5 groups, each group consists of 6 rats.(56)
                  Group                 Treatment
Group I: normal Rats received only normal saline(1ml,p.o) for 14 
consecutive days
Group II: control Rats received 0.1ml of 6% acetic acid solution 
intrarectally.
Group III: Standard Rats received prednisolone (10mg/kg,p.o), for 3days 
and 0.1ml of 6% acetic acid solution for 2days.
Group IV: CHSG and 
EASG(400mg/kg) Rats received 12days pretreatment with CHSG and 
EASG and 0.1ml of 6% acetic acid solution,intrarectally  
on 13th and 14th day.Group V: CHSG and EASG 
(400mg/kg)
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Procedure:
Rats (200-250g) were used for the study. overnight fasted animals both the treated and control 
group animals were instilled with 0.1ml of 6% acetic acid solution into the rectum of the rats 
.Animals were allowed to hang in air by holding their tails for 1-2min.This prevented the spillage 
of the solution from the rectum
          After 48hours animals were Sacrificed by cervical dislocation and dissected to remove the 
colon and caecum. Colon and Caecum was flushed gently with saline,cut open and scored for 
inflammation based on the macroscopic features.Tissues were fixed in 10% formalin saline and 
examined histopathologically.
            Quantification of inflammation was done using myeloperoxidase assay.(31)(57)(56).
EVALUATION OF PARAMETERS OF INFLAMMATORY BOWEL DISEASE.
The disease induced induced experimental animals was evaluated based on its macroscopic and 
microscopic characteristics. Evaluation pattern for macroscopic characteristics was used after 
some modifications.The inflammation was quantified using myeloperoxidase assay.
1. Assessment of Myeloperoxidase activity: myeloperoxidase enzyme activity was 
determine to measure the inflammation in the intestinal tissues.It was measured by using 
DTNB method.(58)
2. Assessment of oxidative stress: Oxidative stress was determined using Lipid 
peroxidation levels in the Intestinal mucosa as an indicator of stress level. The intestinal 
mucosa was scraped out from each animal and homogenized with potassium phosphate 
buffer. (55).
3.Histological evaluation:-
A portion of the intestine of each rat was collected and fixed in 10 % Buffered neutral 
formalin. Sections were stained with haematoxylin and eosin(31)
3. Scoring of the animal intestinal tissues; The intestinal tissues, 5 cm  proximal 
duodenum, 10 cm distal jejunum, 10 cm proximal ileum, whole caecum  and  5 cm 
proximal colon were isolated and were scored visually for inflammation based on 
macroscopic features using following pattern.(31)(56)(54)
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Table 5: Scoring pattern for rat duodenum, jejunum, ileum, caecum and colon in 
indomethacin induced enterocolitis(31)(56)(54)
Score Macroscopic changes
0 No visible change
1 Hyperemia at sites
2 Loss of mucosal integrity
3 Lesions having diameter 1 mm or less
4 Lesions having diameter 2 mm or less (no<5)
5 Lesions having diameter 2 mm or less (no 5-10)
6 Lesions having diameter 2 mm or less (no>10)
7 Lesions having diameter more than 2 mm (no<5)
8 Lesions having diameter More than 2 mm (no 5-10)
9 Lesions having diameter more than 2 mm ( no>10)
Scoring for rat caecum and colon:Rat caecum and colon(5cm long ) was scored for macroscopic 
feature using following scoring pattern.(31)(56)
Table 6: Scoring pattern for rat caecum and colon in acetic acid induced enterocolitis
Score Percentage area affected
0 0
1 1-5
2 5-10
3 10-25
4 25-50
5 50-75
6 75-100
Samples were isolated and washed with normal saline and stored for in vivo antioxidant studies. 
The tissues were homogenized with motor driven Teflon coated homogenizer in ice-cold (10% 
w/v) 0.1 M Tris-HCl buffer pH 7.4 to get 10% homogenate. The homogenate was centrifuged at 
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10000 rpm for 10 min at 5˚C. The supernatant was collected and used for following in vivo 
studies.(31)
3.2.8.3.MYELOPEROXIDASE ASSAY FOR QUANTIFICATION OF INFLAMMATION:
Principle: Mpo activity enzyme is a measure of leukocyte infiltration.It oxidizes tyrosine to 
tyrosyl radical using hydrogen peroxide as an oxidizing agent. The enzyme involves in the 
nitration of tyrosine residues,which cause variety of inflammatory disorders.(59)
Procedure:
Pieces of inflamed tissues were taken.The tissues was then rinsed with saline,blotted dry, weighed 
and excised.Minced tissue was homogenized in phosphate buffer (pH 7.4), using remi tissue 
homogenizer.The homogenate was centrifuged at 10000 rpm for 20min at 40C. supernatant was 
discarded,myeloperoxidase activity was measured by DTNB method as follows:
            0.1ml of tissue homogenate was treated with 0.1ml of TNB and 1ml of sodium acetate 
buffer followed by addition of about 0.8ml of Nacl solution and 35μl of hydrogen peroxide.The 
change in absorbance was measured spectrophotometrically at 490nm.(58)
          One unit of MPO activity is defined as the change in absorbance per minute by 1.0 at room 
temperature, in the final reaction.(31)
3.2.8.4. IN VIVO ANTIOXIDANT ACTIVITY
3.2.8.5. Preparation of tissue homogenate
For the estimation of non-enzymatic and enzymatic antioxidants, tissue was minced and 
homogenized (10% w/v) in 0.1 M phosphate buffer (pH 7.0) and centrifuged for 10 min and the 
resulting supernatant was used for enzyme assays.(31)
3.2.8.4.1. ESTIMATION OF PROTEINS:
Reagents
· Alkaline copper reagent
· Solution A: 2% sodium carbonate in 0.1 N NaOH.
· Solution B: 0.5% copper sulphate in 1% sodium potassium tartarate
· Solution C: 50 ml of solution A was mixed with 1 ml of solution B just before use.
· Folin’s phenol reagent (commercial reagent, 1:2 dilutions) Bovine serum albumin
(BSA).
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Principle:
This method involves two steps;
Step: 1- -protein binds with copper in alkaline medium and reduces it into cu++.
Step: 2- the cu++ formed catalyses the oxidation reaction of aromatic amino acids by reducing 
phosphomolybdotungstate to heteropolymolybdanum, which leads to the formation of blue colour 
and absorbance was measured at 640 nm.(60)
Procedure:
0.1 ml homogenate was made up to 1 ml with distilled water and to this; 5 ml of alkaline solution 
was added, mixed well and allowed to stand for 10 min. Then a volume of 0.5 ml Folin’s reagent 
was added, mixed well and incubated at room temperature for another 10 min. The blue colour 
developed was measured at 660 nm against blank. Bovine serum albumin (1 mg/ml) served as the 
standard and form the standard graph obtained; the amount of protein in the sample was 
calculated and expressed as mg/100 mg tissue.
3.2.8.4.2. ENZYMATIC ANTI-OXIDANT ACTIVIY
3.2.8.4.2a. ESTIMATION OF CATALASE (CAT)
Reagents
· Dichromate acetic acid reagent (5% potassium dichromate + glacial acetic acid
were mixed at 1: 3 ratio (v/v).
· 0.01M Phosphate buffer (pH-7.0).
· 0.2M hydrogen peroxide.
Principle:
The normal antioxidant activity of the enzyme catalase is due to acceleration of
decomposition of hydrogen peroxide to water and oxygen. This method is based on
the principle that by measuring the rate of decomposition of hydrogen peroxide by the enzyme 
catalase spectrophotometrically at 570 nm, since hydrogen peroxide has the absorbance at this 
range.(61)
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Procedure:
To 1 ml of tissue homogenate 4 ml of hydrogen peroxide and 5 ml of phosphate buffer was added 
and mixed well. From this, 1 ml of solution was taken and mixed
with dichromate acetic acid reagent and allowed to incubate for 30 min at room
temperature. The absorbance was measured at 570nm. The activity of catalase was
expressed as μ mole of H2O2 consumed /min/mg protein.
3.2.8.4.2b. ESTIMATION OF SUPEROXIDE DISMUTASE (SOD)
Reagents
· 50mM tris Hcl buffer at pH 8.2
· 10mM pyrogallol
· 10mM Hcl
Principle:
Pyrogallol autoxidizes rapidly in aqueous solution, where the reaction will be faster at higher pH, 
and leads to the formation of several intermediate products. Thus the solution first becomes 
yellow-brown with a spectrum showing a shoulder between 400 and 425nm. Molecular oxygen, 
carrying two unpaired electrons with parallel spins, has a preference for univalent reduction 
because spin restrictions arise when reduction with electron pairs is attempted. The recently 
discovered enzyme superoxide dismutase  rapidly dismutases univalently reduced oxygen O2.
-
i.e., the superoxide anion radical (2O2.
-, + 2 H+         O2+ H2O2). The enzyme has proven to be a 
useful probe for studying the participation of the radical in reactions involving oxygen such as 
autoxidations. Thus O2
-. has been shown to be involved in the autoxidation of e.g. sulphite, 
adrenalin  and 6-hydroxydopamine.(62)
Procedure
This method might be used for determination of antioxidant activity of a sample, and it was 
described by McCord and Fridovich. The main purpose of this method that was estimated 5% of 
tissue homoginate after adding 75mM, 30mM, and 2mM from Tris-HCL (pH 8.2), EDTA, and 
pyrogallol respectively. Then, the absorbance was measured at 420nm. The percentage of 
inhibition was calculated depending on that the ability of enzyme to inhibit of oxidation. So, any 
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changes might be happened on the absorbance, it will give a clear picture on the ability of enzyme 
activity to prevent oxidation.(63)
3.2.8.4.2c. ESTIMATION OF GLUTATHIONE PEROXIDASE (GPx)
Reagents
· 0.32 M Phosphate buffer, pH 7.0
· 0.8 mM EDTA
· 10 mM Sodium azide
· 3 mM reduced glutathione
· 2.5 mM H2O2
· 10 % TCA
· 0.3 M Disodium hydrogen phosphate
· DTNB solution (40 mg of DTNB in 100 ml of 1% sodium citrate)
· Reduced glutathione
Principle:
The principle behind the assay is the reduction of hydrogen peroxide (H2O2), by
glutathione peroxidase through simultaneous oxidizing of reduced glutathione (GSH) to form 
oxidized glutathione (GSSG). GSSG is again reduced by glutathione reductase (GR) and β-
nicotinamide adenine dinucleotide phosphate (NADPH) forming NADP+ which results in the 
decreased absorbance at 340 nm and recycling the GSH. The decrease in absorbance at 340 nm is 
directly proportional to the GPx concentration.(64)
Procedure
To 0.1 ml of the tissue homogenate, 0.2 ml of EDTA, sodium azide, hydrogen
peroxide were added and mixed. Then 0.4ml of phosphate buffer was added and
allowed to incubate at room temperature. The reaction was arrested by the addition
of 0.5 ml of TCA. The reaction mixture was centrifuged at 5000 rpm for 10 min and the 
supernatant was collected. To 0.5ml of the supernatant 4 ml of disodium
hydrogen phosphate and 0.5 ml of DTNB were added and the colour developed was read 
immediately at 420 nm. The activity of Glutathione peroxidase was expressed as μmoles of 
glutathione oxidized/min/mg.
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3.2.8.4.3. NON ENZYMATIC ANTIOXIDANT ACTIVITY
3.2.8.4.3a. ESTIMATION OF REDUCED GLUTATHIONE (GSH)
Reagents
· 5% TCA
· 0.6 mM 5,5’-dithiobis-2-nitrobenzoic acid ( DTNB) in 0.2 M sodium
phosphate
· 0.2 M Phosphate buffer, pH 8.0
Principle:
DTNB known as Ellman’s reagent was developed for the detection of thiol
compounds. DTNB and sulfhydryl groups present in glutathione (GSH) react to
generate 2-nitro-5- thiobenzoic acid and glutathione disulfide (GSSG). Since 2-nitro-5-
thiobenzoic acid is a yellow coloured product, GSH concentration in a sample solution can be 
determined by the measurement at 412 nm.(65)
Procedure:
To 1ml of the homogenate, 1ml of the TCA solution was added and centrifuged. The supernatant 
was collected and the precipitate formed was removed. To 0.5 ml of supernatant 2 ml of DTNB 
was added, the volume was made up to 3 ml with
phosphate buffer. Then absorbance was read at 412 nm. The amount of glutathione was expressed 
as μg/mg protein.
3.2.8.4.3b. DETERMINATION OF LIPID PEROXIDATION
Reagents
 Thiobarbituric acid 0.37%
 0.25 N HCL
 15% TCA
Principle:
This assay is based on the reaction between Thiobarbituric acid with
malonyldialdehyde which is formed as a result of polyunsaturated fatty acid
oxidation. This reaction leads to the formation of pink coloured TBA-MDA complex which is 
measured at 532 nm.(61)
                                                                                                                    Materials and Methods
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Procedure:
To 0.1 ml of the sample, 2 ml of TBA-TCA-HCL reagent (ratio of 1:1:1) was added mixed and 
kept in a water bath for 15 minutes. Afterwards the solution was cooled and supernatant was 
removed and the absorbance was measured at 535 nm against reference blank. The level of lipid 
peroxidase was given as n moles of MDA formed/mg protein.
3.2.9.HISTOPATHOLOGICAL STUDIES
The tissues duodenum,jejunum,ileum,colon and caecum of all rats were isolated  and were fixed 
in 10% formalin solution. The tissues were trimmed and prepare 5μm thick paraffin sections and 
stained in haematoxyline and eosin.The stained sections were examined for any inflammatory 
changes like infiltration of cells, necrotic foci, damage to tissue structures like payers patches, 
damage to nucleus,etc.(31)
3.2.9.1.HISTOPHATOLOGICAL TECHINIQUES
Histopathology is the microscopical study of tissues for pathological alterations. This 
involves collection of morbid tissues from biopsy or necropsy, fixation, preparation of sections, 
staining and microscopical examination.
1) Collection of materials
         Thin pieces of 3 to 5 mm, thickness were collected from tissues showing gross morbid 
changes along with normal tissue.
2) Fixation:
Kept the tissue in fixative for 24-48 hours at room temperature
The fixation was useful in the following ways:
a) Serves to harden the tissues by coagulating the cell protein,
b) Prevents autolysis,
c) Preserves the structure of the tissue, and 
d) Prevents shrinkage 
e) Common Fixatives: 10% Formalin                            
                                                                                                                    Materials and Methods
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3) Haematoxylin and eosin method of staining:
Deparaffine  the section by xylol 5 to 10 minutes and remove xylol by absolute alcohol. Then 
cleaned the section in tap water and stained with haematoxylin for 3-4 minutes and again cleaned 
under tap water. Allow the sections in tap water for few minutes and counter stained with 0.5% 
eosin until section appears light pink    15 to 30seconds), and then washed in tap water. Blotted 
and dehydrated in alcohol and  cleared with xylol    15 to 30 seconds). Mounted on a Canada 
balsam or DPX Moutant and kept the slide dry and remove air bubbles.(31)
3.2.10. STATISTICAL ANALYSIS
The data’s of all the parameters were analysed using the software SPSS version 16 software The 
data’s of all parameters were analysed by means of one way ANOVA (Analysis of Variance) 
followed by Dunnet’s test. The results were expressed as mean ± SEM.
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4.RESULTS
4.1. EXTRACTIVE YIELD OF Simarouba glauca LEAF EXTRACTS
Percentage Yield of CHSG and EASG
Coarsely powdered Simarouba glauca  aerial leaves  were extracted with chloroform and 
Ethylacetate using soxhlet apparatus after deffating with petroleum ether and the percentage
yield was found to be 
Ethyl acetate extract               2.85%
Chloroform extract                5.12%
4.2. PRELIMINARY PHYTOCHEMICAL ANALYSIS
Table 7: Phytochemical Analysis of CHSG and EASG
Sl.No Phytochemical constituents CHSG and EASG
1 Carbohydrate Positive
2 Alkaloids Positive
3 Triterpenoid Positive
4 Glycosides Positive
5 Steroid and sterols Positive
6 Phenols Positive
7 Tannins Positive
8 Saponins Positive
9 Phenols Positive
10 Proteins and Amino acids Positive
4.3. HPTLC SCREENING ANALYSIS OF EASG & CHSG
HPTLC study was carried out for the quantification of β-sitosterol in extract. Visualization was 
performed as done  (figure 5 ) and the selected mobile phase gave Rf values( 0.40) for β-
sitosterol . After development the plate was scanned in densitometer under 366nm and the 
chromatogram obtained is depicted in figure 6. The calibration curve was prepared by plotting 
the concentration of β-sitosterol versus average area of peak (table 9, figure 8 ). The amount of
β-sitosterol present in the extract was computed from calibration curve (Table 10 ).
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Figure 5: Detection of bands 
Table 8:Lists of spots applied on HPTLC plate
Track number Sample
T1 EASG(10μl)
T2 CHSG(10μl)
S1 β-sitosterol(1μl)
S2 β-sitosterol(3μl)
S3 β-sitosterol (5μl)
S4 β-sitosterol(7μl)
S5 β-sitosterol(10μl)
S6 β-sitosterol(12μl)
S7 β-sitosterol (15μl)
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Figure 6: Chromatogram of β-sitosterol and CHSG & EASG
1: chromatogram of EASG (10μl) 2: chromatogram of CHSG (10μl)
3: chromatogram of β-sitosterol(1μl)   4: chromatogram of β-sitosterol(3μl)
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5:Chromatogram of β-sitosterol(5μl)  6:chromatogram of β-sitosterol(7μl)
7:  chromatogram of β-sitosterol(10μl 8:Chro matogram of β-sitosterol(12μl)
Results
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Track 9:Chromatogram of β-sitosterol(15μl)
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Figure 7 : 3D display of β-sitosterol and EASG &CHSG
Figure 8: Calibration curve of β-sitosterol
Results
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Table 9: Responses obtained for β-sitosterol in preparation of calibration curve for HPTLC 
studies
Track Rf Volume 
applied (μl)
Area Remark
3 0.40 1 314.31 β-sitosterol
4 0.40 3 1198.94 β-sitosterol
5 0.39 5 943.97 β-sitosterol
6 0.39 7 727.42 β-sitosterol
7 0.39 10 769.50 β-sitosterol
8 0.40 12 1537.52 β-sitosterol
9 0.41 15 2520.62 β-sitosterol
Table 10: Quantification of  β-sitosterol in CHSG & EASG sample by HPTLC
Volume applied 
(μl)
Area Amount of  β-
sitosterol 
present(µg)
% of β-sitosterol
In 100 mg/g 0f 
extract
(EASG 
extract)10μl
16849.49 42.16 4.21
(CHSG 
extract)10μl
20538.19 51.39 5.13
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4.4. QUANTIFICATION OF TOTAL PHENOL AND FLAVANOIDS.
4.4.1. ESTIMATION OF TOTAL PHENOL
Table 11: Estimation of total phenolic content of CHSG & EASG.
Sl.no Sample Concentration(µg/ml) Absorbance
1
Gallic acid 1mg/ml (standard)
10 0.0498
20 0.0971
40 0.1907
60 0.2983
80 0.410
100 0.5086
2 CHSG & EASG 1mg/ml(sample) Chloroform-1000 1.4928
Ethylacetate-1000 1.1589
The total phenolic content for EASG extract was found to be 118.35mg/g whereas CHSG extract 
was found to be 148.709 mg/g calculated as gallic acid equivalent.
Figure 9: Estimation of total phenolic content of CHSG & EASG
y = 0.0115x - 0.1437
R² = 0.9868
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4.4.2.ESTIMATION OF TOTAL FLAVONOID CONTENT.
Table 12: Quantification of Total Flavanoid Content of EASG & CHSG
Sl.No Sample Concentration Absorbance
1 Quercetin 1mg/ml (standard) 10 0.031
20 0.085
40 0.26
60 0.5026
80 0.776
100 1.053
2 CHSG &EASG 1mg/ml 
(sample
Chloroform-1000 0.9701
Ethylacetate-1000 0.7046
The total flavanoid content of EASG extract was found to be 77.05mg/g whereas CHSG extract 
was found to be 101.19mg/g calculated as quercetin equivalent.
Figure 10: Estimation of total flavonoid content of CHSG & EASG
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4.5. IN VITRO ANTIOXIDANT ACTIVITY STUDY IN EASG & CHSG.
4.5.1.DPPH RADICAL SCAVENGING ACTIVITY
Table 13: % inhibition and IC50 values of DPPH radical by ascorbic acid
Sl.No Concentration 
(μg/ml) 
% inhibition IC 50 (μg/ml)
1 5 66.58
2.989
2 10 74.34
3 15 80.58
4 20 87.48
5 25 94.56
6 30 99.38
Figure 11:DPPH radical scavenging activity of Ascorbic acid
0 10 20 30 40
60
70
80
90
100
110
Concentration mg/ml
%
in
hi
bi
tio
n
Results
Department of Pharmacology, KMCH College of Pharmacy Page 59
Table 14 : % inhibition and IC50 values of DPPH radical by CHSG
Sl.No Concentration 
(µg/ml)
%inhibition IC50 (µg/ml)
1 10 48.29
11.94
2 15 50.23
3 20 56.20
4 25 62.04
5 50 68.28
6 100 73.19
Figure 12:DPPH radical scavenging activity of CHSG
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Table 15 : % inhibition and IC50 values of DPPH radical by EASG
Sl.No Concentration(µg/ml) % inhibition IC50
1 10 42.67
15.97
2 15 46.45
3 20 55.31
4 25 59.32
5 50 65.36
6 100 76.12
Figure 13: DPPH radical scavenging activity of EASG
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4.5.2. TOTAL ANTIOXIDANT ACTIVITY BY ABTS RADICAL CATION ASSAY IN 
EASG & CHSG.
Table 16: % inhibition of ABTS radical by Ascorbic acid.
Sl.No Concentration(µg/ml) %inhibition IC50
1 0.25 70.08
0.1142
2 0.5 75.22
3 0.75 79.62
4 1 85.88
5 1.25 91.9
6 1.5 98.85
Figure 14: ABTS radical scavenging activity of Ascorbic acid
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Table 17: % inhibition and IC50 values of ABTS radical by  EASG
Sl.No Concentration (µg/ml) % inhibition IC50
1 1 53.61
1.160
2 2 57.41
3 3 61.63
4 4 71.18
5 5 76.92
6 10 97.37
Figure 15: ABTS radical scavenging activity of EASG
0 5 10 15
0
50
100
150
Concentration mg/ml
%
 in
hi
bi
tio
n
Results
Department of Pharmacology, KMCH College of Pharmacy Page 63
Table 18: % inhibition and IC50 values of ABTS radical by  CHSG
Sl.No Concentration(µg/ml) % inhibition IC50 (µg/ml)
1 1 50.67
1.134
2 2 56.04
3 3 61.34
4 4 65.32
5 5 68.45
6 10 79.36
Figure 16: ABTS radical scavenging activity of CHSG
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4.6. INVITRO CYTOTOXICITY STUDY OF EASG & CHSG. 
4.6.1. MTT assay on CaCO2 with EASG extract.
Table 19: Cytotoxic properties of EASG against MTT assay on CaCO2 .
Sl.no Name of the test sample Test Conc.
( µg/ml)
% cytotoxicity CTC50
( µg/ml)
1 EASG extract(1mg/ml)
62.5
125
250
500
1000
8.67±4.6
13.35±1.1
19.01±2.3
25.90±2.1
57.38±0.6
883.33±5.8
Figure 17:  cytotoxicity properties of EASG extract against MTT assay on caco2.
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Figure 18: Representative photo micrograph shows morphological changes of Caco2 cell 
lines with EASG extract.
CONTROL     CaCo2
EASG extract 500 (µg/ml)                              EASG extract 1000 (µg/ml)
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4.6.2. MTT assay on CaCO2 with CHSG Extract.
Table 20: % cytotoxicity properties of CHSG against MTT assay on CaCo2. 
Sl. 
No
Name of 
Test sample
Test Conc.
( µg/ml)
% cytotoxicity
CTC50
( µg/ml)
2 CHSG extract(1mg/ml)
62.5
125
250
500
1000
5.04±4.8
6.53±4.8
13.13±3.2
17.37±2.6
24.48±1.3
>1000
Figure 19: cytotoxicity properties of CHSG extract against MTT assay on caco2
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Figure 20: representative photo micrograph shows morphological changes of Caco2 cell 
lines with CHSG extract.
CONTROL CaCo2
CHSG extract 500 (µg/ml)                                  CHSG extract1000 (µg/ml )
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4.7. EVALUATION OF INFLAMMATORY BOWEL DISEASE OF CHSG& EASG.
4.7.1.INDOMETHACIN-INDUCED ENTEROCOLITIS .
Table 21:Evaluation based on bodyweight in indomethacin induced enterocolitis
Groups 1st day body weight 14th day body weight
Group-1normal 141.2±5.069 163.7±4.402
Group-II control 143±7.956 89.67±2.692***
GROUP-IIIStandard 149±16.06 119.7±8.086***
GROUP-IVEASG treated 138.0±7.412 111.7±4.201*
GROUP-VCHSG treated 139.0±4.211 121.3±3.836***
Figure 21:Body weight analysis 
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One way Annova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of Inflammatory bowel 
disease  control with vehicle control and ns- non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory bowel disease control
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Table 22: Evaluation based on macroscopic feature in Indomethacin- induced enterocolitis.
Group Treatment Mean of macroscopic 
scores ± S.E.M
Group I: normal Only normal saline 0.0±0.0
Group II: control Indomethacin (7.5mg/kg,s.c) 5.667±0.1520***
Group III: Standard Prednisolone(10mg/kg,orally) and 
indomethacin(7.5mg/kg))
1.000±0.2191***
GroupIV:EASG(400mg/kg) Ethyl acetate extract of simarouba 
glauca (400mg/kg) and 
indomethacin (7.5mg/kg)
1.133±0.2765***
GroupV:CHSG (400mg/kg) Chloroform extract of Simarouba 
glauca (400mg/kg,orally) and 
indomethacin (7.5mg/kg
2.200±0.4099***
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One way Annova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of Inflammatory bowel 
disease  control with vehicle control and ns- non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory bowel disease control
.
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Figure 22 :Effect of EASG & CHSG extract on Macroscopic features in indomethacin 
induced enterocolitis
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Table 23: Evaluation based on MPO activity in Indomethacin-induced enterocolitis.
Group Treatment MPO activity(U/g)± S.E.M
Group I: normal Only normal saline 6.733±0.1695
Group II: control Indomethacin (7.5mg/kg,s.c) 24.90±0.2769***
Group III: Standard Prednisolone(10mg/kg,orally) and 
indomethacin(7.5mg/kg)
8.473±0.1314***
GroupIV:EASG(400mg/kg) Ethyl acetate extract of simarouba 
glauca (400mg/kg) and 
indomethacin (7.5mg/kg)
14.77±0.1520***
GroupV:CHSG (400mg/kg) Chloroform extract of simarouba 
glauca (400mg/kg,orally) and 
indomethacin (7.5mg/kg
12.69±0.2143***
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One way Annova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of Inflammatory bowel 
disease  control with vehicle control and ns- non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory bowel disease control.
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Figure 23: Effect of EASG & CHSG extract on MPO activity in indomethacin-induced 
enterocolitis
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4.7.1.1. INTESTINAL IMAGES OF INDOMETHACIN INDUCED ENTEROCOLITIS
Figure 24: Images of control group(untreated)
Duodenum        Jejunum            ileum           Caecum               Colon
Figure 25: Images of normal group
Duodenum jejunum                    ileum           Caecum colon
Figure 26: Images of standard treated group
Duodenum jejunum          ileum                 Caecum Colon
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Department of Pharmacology, KMCH College of Pharmacy Page 74
Figure27: Images of ethyl acetate extract treated group
Duodenum     jejunum ileum caecum Colon
Figure 28: Images of chloroform extract treated group
Duodenum jejunum ileum caecum  colon
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4.7.2.ACETIC ACID-INDUCED ENTEROCOLITIS .
Table 24:Evaluation based on bodyweight in acetic induced enterocolitis.
Groups 1st day body weight 14th day body weight
GroupI-control 126.3±4.177 85.50±3.775***
GroupII-normal 142.2±5.534 163.7±4.402
GroupIII-Standard 131.7±4.595 130.0±3.907***
GroupIV-EASG treated 127.2±5.724 109.3±4.645**
GroupVCHSG treated 134.8±4.556 121.8±5.023***
Figure 29: Body weight analysis of acetic acid induced enterocolitis
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One wayAnnova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of inflammatory 
bowel disease control with vehicle control and ns- non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory Bowel disease control.
0
50
100
150
200
250
300
350
Control normal standard EASG CHSG
14th day
1st day
GROUPS
BO
D
Y 
W
EI
G
H
T(
g)
BODY WEIGHT ANALYSIS
Results
Department of Pharmacology, KMCH College of Pharmacy Page 76
Table 25: Evaluation based on macroscopic features in acetic acid-induced enterocolitis.
Groups Treatment Mean of macroscopic 
scores ± S.E.M
Group I: normal Only normal saline 0.0±0.0
Group II: control 6% acetic acid 
solution,intrarectally 3.667±0.5426***
Group III: Standard Prednisolone(10mg/kg,orally) and 
6% acetic acid 
solution,intrarectally
0.7500±0.2419***
GroupIV:EASG(400mg/kg) Ethyl acetate extract of Simarouba 
glauca (400mg/kg) and 6% acetic 
acid solution,intrarectally
2.500±0.1826*
GroupV:CHSG (400mg/kg) Chloroform extract of Simarouba 
glauca (400mg/kg,orally) and 6% 
acetic acid solution intrarectally.
1.917±0.3005**
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One wayAnnova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of inflammatory 
bowel disease control with vehicle control and ns- non significant *P<0.05, **P<0.01, and
***P<0.001 denotes comparison of all groups with Inflammatory Bowel disease control.
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Figure 30: Effect of EASG and CHSG on macroscopic features in acetic-acid induced 
enterocolitis
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Table 26: Evaluation of MPO activity in acetic acid-induced enterocolitis.
Group Treatment MPO activity(U/g)± S.E.M
Group I: normal Only normal saline 6.733±0.1695
Group II: control 6% acetic acid 
solution,intrarectally
14.74±0.2365***
Group III: Standard Prednisolone(10mg/kg,orally) and 
6% acetic acid 
solution,intrarectally
7.564±0.3992***
GroupIV:EASG(400mg/kg) Ethyl acetate extract of simarouba 
glauca (400mg/kg) and 6% acetic 
acid solution,intrarectally
13.18±0.3600**
GroupV:CHSG (400mg/kg) Chloroform extract of simarouba 
glauca (400mg/kg,orally) and 6% 
acetic acid solution intrarectally.
12.15±0.2311***
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One wayAnnova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of inflammatory 
bowel disease control with vehicle control and ns-non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory Bowel disease control.
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Figure 31: Effect of EASG & CHSG on MPO in acetic acid induced enterocolitis
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4.7.2.1.IMAGES OF CAECUM AND COLON IN ACETIC ACID INDUCED 
ENTEROCOLITIS
Figure 32:Images of control group
Caecum                                              Colon
Figure 33: Images of standard treated group 
Colon                                                       Caecum
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Figure 34:Images of ethyl acetate extract treated group
Colon Caecum
Figure 35: Images of chloroform extract treated group
Colon                                                Caecum
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4.8.ESTIMATION OF TOTAL PROTEIN
Table 27: Effect of CHSG &EASG on total protein in intestinal tissue of indomethacin 
induced enterocolitis
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One wayAnnova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of inflammatory 
bowel disease control with vehicle control and ns-non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory Bowel disease control.
Groups Total protein
(mg/100mg of tissue)
GroupI-normal
7.282±0.3772
GroupII-control
3.805±0.3036***
Group III-Standard
6.528±5.753**
Group IV-CHSG(400mg/kg)
6.005±0.5716**
Group V-EASG(400mg/kg)
5.753±0.5709*
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Figure 36: Effect of EASG and CHSG extract on total protein in indomethacin induced 
enterocolitis
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4.9. INVIVO ANTIOXIDANT ACTIVITY
Table 28: Effect of CHSG &EASG on Invivo antioxidants of intestinal tissues of 
indomethacin-induced enterocolitis in rats.
Groups SOD(unit/min/
mg protein)
CAT ( μmol
of H2O2
consumed/
min/ mg
protein)
GSH
(Glutathio
ne
μg/mg)
GPx(nmol of 
glutathione 
oxidized/min/
mg protein)
LPO (nmol 
of 
MDA/mgpr
otein
Control
1.920±0.2487**
*
15.48±0.5160**
*
8.452±0.34
87***
12.25±0.3374*
**
21.83±0.749
1***
normal 6.988±0.2028 50.02±0.8185 16.39±0.33
67
31.25±1.588 8.350±0.360
3
Standard 4.965±0.1803**
*
29.14±0.6283**
*
13.57±0.20
49***
24.40±0.4574*
**
9.971±0.314
7***
EASG 
treated
3.083±0.2283** 17.78±0.4095* 10.37±0.34
95**
15.28±0.4778* 18.67±0.666
7**
CHSG 
treated
3.400±0.2299**
*
18.87±0.4711** 12.44±0.66
41***
16.87±0.4793*
*
13.83±0.477
3***
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One wayAnnova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of inflammatory 
bowel disease control with vehicle control and ns-non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory Bowel disease control.
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Figure 37: Effect of EASG& CHSG on SOD in indomethacin induced enterocolitis
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Figure 38: Effect of EASG& CHSG on catalase  in indomethacin induced enterocolitis
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Figure 39: Effect of EASG& CHSG on GSH  in indomethacin induced enterocolitis
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Figure 40: Effect of EASG& CHSG on GPx  in indomethacin induced enterocolitis
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Figure 41: Effect of EASG& CHSG on LPO  in indomethacin induced enterocolitis
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Table 29: Effect of CHSG &EASG on total protein in intestinal tissue of acetic acid 
induced enterocolitis
Groups Total protein
(mg/100mg of tissue)
GroupI-normal 5.663±0.3288
GroupII-control 1.825±0.2687***
GroupIII-Standard prednisolone(10mg/kg) 5.167±0.2045***
Group IV- CHSG(400mg/kg) 4.058±0.3084***
Group V-EASG(400mg/kg) 3.556±0.2045**
Figure 42: Effect of EASG& CHSG on total protein  in acetic-acid  induced enterocolitis
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Table 30: Effect of CHSG &EASG on Invivo antioxidants of intestinal tissues of Acetic acid 
-induced enterocolitis in rats.
Groups SOD(unit/mg 
protein)
CAT ( μmol
of H2O2
consumed/
min/ mg
protein)
GSH
(Glutathione
μg/mg)
GPx(nmol of 
glutathione 
oxidized/min/
mg protein)
LPO (nmol of 
MDA/mg
protein
Control 0.9120±0.02899
***
12.83±0.2256
***
6.742±0.4268
**
14.98±1.363**
*
24.71±0.4423
***
normal 4.273±0.2593 64.25±1.225 15.19±0.3236 27.98±0.5553 5.926±0.1193
Standa
rd
3.475±0.1226**
*
19.16±0.4695
***
12.79±0.3493
***
22.05±0.3376*
**
8.108±0.5766
***
EASG 
treated
1.826±0.1855* 16.10±0.5035
**
8.329±0.3530
*
18.71±0.8231* 21.73±0.7119
**
CHSG 
treated
2.222±0.3515** 17.20±0.5681
***
10.87±0.2534
***
19.38±0.7954*
*
16.42±0.5457
***
Statistical comparison: Each group (n=6), each value represents Mean ± SEM. One wayAnnova 
followed by Dunnett’s test was performed. aP<0.001 denotes comparison of inflammatory 
bowel disease control with vehicle control and ns-non significant *P<0.05, **P<0.01, and 
***P<0.001 denotes comparison of all groups with Inflammatory Bowel disease control.
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Figure 43: Effect of EASG& CHSG on SOD inacetic acid induced enterocolitis
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Figure 44: Effect of EASG& CHSG on Catalase in acetic acid induced enterocolitis
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Figure 45: Effect of EASG& CHSG on GSH  in acetic acid induced enterocolitis
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Figure 46: Effect of EASG& CHSG on GPx  in acetic acid induced enterocolitis
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Figure 47: Effect of EASG& CHSG on LPO in acetic acid induced enterocolitis
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4.10.HISTOPATHOLOGICAL STUDY
4.10.1.Indomethacin-induced enterocolitis in rats
Figure 48 :GROUP-I (normal group)
Duodenum             jejunum              ileum                 Caecum        colon
∑ Section from duodenum shows normal epithelium. Lamina propria shows few scattered 
lymphocytic infiltrates. Submucosa and connective tissues shows no significant 
pathology. Muscular layer shows normal morphology. There is no 
malignancy/granuloma/IBD seen in the section studied.
∑ Section from jejunum shows normal mucosa. Lamina propria shows very mild 
lymphocytic infiltrates. Muscular layer shows normal. There is no evidence of 
malignancy/granuloma/IBD seen in the section studied.
∑ Section from ileum shows normal epithelium. Lamina propria shows few scattered 
lymphocytic infiltrates. Muscular layer and serosa shows normal morphology. There is 
no malignancy/granuloma/ IBD seen in the section studied.
∑ Section from caecum shows normal mucosa.Lamina propria shows normal 
morphology.Muscular layer shows normal.There is no evidence of cryptitis and crypt 
abscess.
∑ Section from colon shows normal epithelium. Lamina propria shows few scattered 
lymphocytic infiltrates and connective tissues. There is no malignancy/granuloma seen.
Results
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Figure 49: GROUP-II (Indomethacin control group)
Duodenum         jejunum                    ileum                caecum                          colon
∑ Section from duodenum shows focal surface ulceration. Lamina propria shows 
lymphoplasmacytic infiltrates. Submucosa shows dilated blood vessels. Muscular layer 
and serosa shows no significant pathology. 
∑ Section from jejunum shows epithelial ulceration with focal necrosis and edema, surface 
shows transudates. Lamina propria shows lamina propria shows lymphoplasmacytic 
infiltrates. Muscular layer and serosa shows normal. 
∑ Section from ileum shows focal surface ulceration. Lamina propria shows moderate 
lymphocytic infiltrates. Submucosa shows peyer’s patches. Muscular layer and serosa 
shows normal morphology.
∑ Section from caecum shows full thickness necrosis (gangrene). Lamina propria shows 
dense inflammatory infiltrates. Muscular layer shows no significant pathology. Serosa 
shows mild inflammatory infiltrates. Consistent with gangrene.
∑ Section from colon mucosa shows epithelial ulceration. Lamina propria shows dense 
lymphocytic infiltrates and few glands shows loss of architecture (cryptitis). Muscular 
layer and serosa shows no significant pathology. 
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Figure 50: GROUP-III (standard treated group)
Duodenum          jejunum               ileum                 caecum                    colon
∑ Section from duodenum shows epithelial ulceration. Lamina propria shows  scattered 
lymphocytic infiltrates. Submucosa shows dilated blood vessels. Muscular layer and 
serosa shows no significant pathology
∑ Section from jejunum shows epithelial ulceration. Lamina propria shows chronic 
inflammatory infiltrates on focal shows complete loss of glands. Muscular layer and 
serosa shows normal. There is no evidence of malignancy seen in the section studied.
∑ Section from ileum shows ulceration in the mucosa. Lamina propria shows few 
moderate lymphocytic infiltrates. Muscular layer and serosa shows normal 
morphology.
∑ Section from caecum shows mucosal ulceration, one focal shows full thickness 
ulceration. Lamina propria shows dense inflammatory infiltrates with focal areas 
shows mild cryptitis. Muscular layer shows normal morphology. Serosa shows mild 
inflammatory infiltrates. 
∑ Section from colon shows mucosal ulceration. Lamina propria shows diffuse less 
lymphocytic infiltrates and few glands shows loss of architecture (cryptitis). Muscular 
layer and serosa shows mild inflammation. 
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Figure 51:GROUP-IV (EASG Extract treated group)
Duodenum        jejunum            ileum                caecum              colon
∑ Section from duodenum shows normal epithelium. Lamina propria shows mild 
lymphocytic infiltrates. Muscular layer and serosa shows no significant pathology. There 
is no evidence of malignancy/ granuloma seen in the section studied.
∑ Section from jejunum shows normal epithelium. Lamina propria shows mild lymphocytic 
infiltrates. Muscular layer and serosa shows normal. There is no evidence of 
malignancy/granuloma/IBD seen in the section studied.
∑ Section from Ileum shows focal areas of mucosal ulceration. Lamina propria shows 
inflammatory infiltrates. Submucosa shows peyer’s patches. Muscular layer and serosa 
shows mild inflammatory infiltrates.
∑ Section from caecum shows normal mucosa. Lamina propria shows mild lymphocytic 
infiltrates. Muscular layer shows no significant pathology. Serosa shows no significant 
pathology. There is no evidence of malignancy/granuloma / IBD seen in the section 
studied. 
∑ Section from colon shows normal epithelium. Lamina propria shows mild lymphocytic 
infiltrates. Muscular layer and serosa shows no significant pathology. There is no 
evidence of malignancy/granuloma/IBD seen in the section studied. 
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Figure 52: GROUP-V (CHSG Extract treated group)
Duodenum      jejunum          ileum              caecum           colon
∑ Section from duodenum shows normal epithelium. Lamina propria shows moderate 
lymphoplasmacytic infiltrates. Submucosa shows inflammatory infiltrates. Muscular layer 
shows significant pathology.  Serosa shows mild inflammatory infiltrates.
∑ Section from jejunum shows normal epithelium. Lamina propria shows mild lymphocytic 
infiltrates. Muscular layer and serosa shows normal. There is no evidence of 
malignancy/granuloma/IBD seen in the section studied.
∑ Section from Ileum shows normal mucosal surface. Lamina propria shows mild lymphocytic 
infiltrates. Submucosa shows peyer’s patches. Muscular layer and serosa shows normal 
morphology.
∑ Section from caecum shows normal mucosa. Lamina propria shows edema and chronic 
inflammatory infiltrates. Muscular layer shows no significant pathology. Serosa shows mild 
inflammatory infiltrates. 
∑ Section from colon shows normal epithelium. Lamina propria shows mild lymphocytic 
infiltrates. Muscular layer and serosa shows no significant pathology. There is no evidence 
of malignancy/granuloma/IBD seen in the section studied. 
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4.10.2.Acetic acid-induced enterocolitis in rats
Figure  53:GROUP-I (normal group)
Normal Colon of rat          Normal  Caecum of rat
∑ Section from colon shows normal epithelium. Lamina propria shows few scattered 
lymphocytic infiltrates and connective tissues. There is no malignancy/granuloma seen
∑ Section from caecum shows normal mucosa.Lamina propria shows normal 
morphology.Muscular layer shows normal.There is no evidence of cryptitis and crypt abscess.
Figure 54: GROUP-II (Acetic-acid control)
Acetic acid control of rat colon    Acetic acid control of rat caecum
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∑ Section from colon shows dense lymphoplasmacytic infiltrates in the lamina 
propria.Glands shows lymphocytes (cryptitis)
∑ Section from caecum shows mucosal ulceration with dense lymphoplasmacytic infiltrates 
in the lamina propria. Glands show lymphocytic infiltrates(cryptitis).
Figure 55: Group-III (Standard group)
standard group of rat colon standard group of rat caecum
∑ Section from colon shows normal epithelium.Dense lymphoplasmacytic infiltrates is 
noted in the lamina propria.Glands show mild cryptitis.
∑ Section from caecum shoes normal mucosa.Lamina propria shows normal morphology. 
Muscular layer shows normal. There is no evidence of cryptitis and crypt abscess.
Figure 56: Group-IV ( EASG extract treated group)
EASG extract of rat colon EASG group of rat caecum            
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∑ Section from colon shows normal epithelium.Dense lymphoplasmacytic infiltrates is 
noted in the lamina propria.Glands shows mild cryptitis.
∑ Section from caecum shows mild mucosal ulceration with mild scattered 
lymphoplasmacytic in the lamina propria.Glands show mild lymphocytic 
infiltration(cryptitis).
Figure57 : Group-V (CHSG treated group)
CHSG group of rat colon              CHSG group of rat caecum
∑ Section from colon shows normal epithelium. Mild lymphoplasmacytic infiltrates is 
noted in the lamina propria. Glands show mild cryptitis.
∑ Section from Caecum shows mild mucosal ulceration with mild lymphoplasmacytic 
infiltrates in the lamina propria. Glands show mild lymphocytic infiltrations
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                                             5.DISCUSSION
               The present study was aimed to assess the efficacy of chloroform and ethylacetate 
leaves extract of Simarouba glauca for its anti-inflammatory  activity in indomethacin and acetic 
acid induced enterocolitis in wistar rats. Indomethacin, a non-selective COX inhibitor produces 
enterocolitis. The mechanisms of indomethacin-induced enterocolitis have not been fully 
illustrated, but in previous reports it was suggested that, initial epithelial damage is mediated 
partly by synthesis inhibition of the protective prostaglandins PGE1, PGE2 and prostacylin. In 
addition, luminal bacterial and bacterial products also contribute to the inflammatory response in 
the indomethacin-induced colitis model. Indomethacin induced model  affect  the middle portion 
of small intestine (jejunum and proximal ileum) and most severely the caecum,the mechanism is 
due to decrease level of prostoglandin and generation of free radicals which damage the mucosal 
integrity .
                        Intrarectal administration of dilute solution of acetic acid causes non-transmural 
inflammation characterized by increased neutrophil infiltration into the intestinal tissue, massive 
necrosis of mucosal and submucosal layers, vascular dilation, edema and submucosal ulceration 
that are noteworthy features of human colitis . Acetic acid cause damage to distal colon portion, 
The mechanisms by which acetic acid produces inflammation appear to involve the entry of the 
protonated form of the acid into epithelium, where it dissociates to liberate protons within 
intracellular acidification that are  likely accounts for the epithelial injury. 
Preliminary Phytochemical analysis
Phytochemical screening of Chloroform and Ethylacetate leaves extract of Simarouba glauca 
was carried out and the results showed the presence of carbohydrates, alkaloids, Steroids and 
Sterols, Glycosides, flavanoids, saponins, Tannins & phenolic compounds, proteins and amino 
acids. 
Estimation of phytoconstituents
Flavonoids are the most diverse and widespread group of natural compounds and are likely to be 
the most important natural phenolic compound. These compounds possess a broad spectrum of 
chemical and biological activities including radical scavenging activity. The contents of total 
phenols and flavonoids were estimated by the standard curves and expressed as Gallic acid 
equivalents for total phenols and quercetin equivalent for flavonoids. The amount of total 
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phenolic content in Ethylacetate and chloroform extract leaves of Simarouba glauca  was found 
to be 118.35mg/g and 148.35mg/g respectively calculated as Gallic acid equivalent and the total 
Flavanoids content in the Ethylacetate and chloroform leaves extract of Simarouba glauca was 
found to be 77.05mg/g  and 101.19mg/g respectively calculated as Quercetin equivalent.
High Performance Thin Layer Chromatography Study
  Inorder to justify and quantify the presence of steroids, the extract was  subjected to      HPTLC 
screening against a marker compound β-sitosterol. β-sitosterol is one of the phytosterol(plant 
sterol) which has chemical structure similar to that of cholesterol.It provide a symptomatic relief 
of inflammatory bowel disease. From the results obtained from HPTLC study,it was found that 
CHSG & EASG contains 51.39 & 42.16 μg of  β-sitosterol.
In vitro Antioxidant Activity of ethyl acetate and chloroform leaves extract of Simarouba 
glauca
Antioxidants are compounds that inhibit or delay the oxidation of other molecules by inhibiting 
the initiation or propagation of oxidizing chain reactions. They are radical scavengers which 
protect the human body against free radicals that may cause pathological conditions such as 
ageing, IBD, dementia etc. Therefore in the present study ,the potential of the CHSG & EASG to 
serve as antioxidants was assayed.
The effect of antioxidants on DPPH is thought to be due to their hydrogen donating ability. The 
free radical scavenging activity of the extract was estimated by comparing the %inhibition of 
CHSG &EASG with standard ascorbic acid.IC50 was also calculated to determine the amount of 
extract needed to quench 50% of radicals. A lower value of IC50 indicates a higher antioxidant 
activity. From the results obtained, IC50 value of ascorbic acid and CHSG & EASG was found to 
be 2.989μg/ml and 11.94μg/ml & 15.97μg/ml respectively. The study suggests that the extract 
contains compounds that are capable of donating hydrogen to a free radical in order to remove 
odd electron which is responsible for radical’s reactivity and it could serve as free radical 
inhibitors or scavengers, acting possibly as primary antioxidants.
    The ability of CHSG &EASG to scavenge DPPH could also reflect its ability to inhibit the 
formation of ABTS. ABTS assays presented as an excellent tool in determining the antioxidant 
activity of hydrogen donating antioxidants (Scavengers of lipid peroxyl radicals). From the 
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results obtained in ABTS assay it was found that the extracts scavenged ABTS radicals 
generated by the reaction between ABTS and potassium persulphate. The activity was found to 
be increased in a dose dependent manner. IC50 value of ascorbic acid was found to be 0.1142 
μg/ml  whereas 1.134μg/ml &1.160 μg/ml for CHSG and EASG extracts. Therefore the ABTS 
radical scavenging activity of extract at higher concentrations may have the ability to scavenge 
free radicals, thereby preventing lipid oxidation via a chain-breaking reaction.
Thus from the result obtained it could be concluded that CHSG&EASG shows a good 
antioxidant activity which might be attributed to the presence of phytochemicals such as 
polyphenols. Oxygen derived free radical generation has been implicated in the etiology and 
pathogenesis of inflammatory bowel disease. Superoxide  anion can react with nitric oxide to 
form peroxy nitrite anions and dismutase into hydrogen peroxidase, a reaction that is accelerated 
by SOD.H2O2 can exert its toxic effects mainly through the ferrous ion dependent formation of 
the highly reactive hydroxyl radicals which leads to alteration of lipids, proteins and DNA.
In order to understand the effect of EASG & CHSG extract of simarouba glauca on human 
Inflammatory bowel disease Intestinal epithelial cells, invitro study were conducted using 
cultured MTT Assay on caco2 cell lines. MTT assay is a well-established in vitro method for 
assessing cell viability and cytotoxicity against inflamed cell lines. The CTC 50 values for 
EASG & CHSG of Simarouba glauca was foun the cell lined to be 883.33±5.8 and >1000 
respectively .A significant reduction in cell damage was observed when caco2 cells were 
pretreated with EASG and CHSG extracts when compared to control.
We have studied two experimental animal models for IBD.Intrarectal instillation of acetic acid in 
rats affected only the caecum and distal colon portion. The inflammation was not transmural.
Massive necrosis of mucosal and submucosal layers was observed. The mechanisms by which 
acetic acid produces inflammation appear to involve the entry of the protonated form
of the acid into epithelium, where it dissociates to liberate protons within intracellular 
acidification that most likely accounts for the epithelial injury observed. The inflammatory 
response initiated by acetic acid includes activation of cyclooxygenase and lipooxygenase
pathways.
Indomethacin given subcutaneously in rats affected the middle portion of small intestine 
(jejunum and proximal ileum) and most severely the caecum. The inflammation was not 
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continuous. It showed some patches of normal tissue (skip areas). Also the necrotic foci were 
transmural. These findings suggest that this experimental model resemble Crohn’s disease).The 
pathogenesis of the lesions produced by indomethacin is not clear. Pathogenic mechanism was 
thought to be prostaglandin-related in indomethacin enteropathy in rats. Local changes in 
intestinal microflora were also thought to be important and this is confirmed by reports that germ 
free animals do not develop lesions readily.Thus, the postulated mechanism is that altered 
mucosal prostaglandin synthesis compromises intestinal integrity, resulting in mucosal response 
to the bacterial products.
              There was a significant decrease in the body weight of both the indomethacin and acetic 
acid induced group compared with normal group. The EASG & CHSG extracts treated group 
and the standard prednisolone group showed slight decrease in the body weight compared to 
indomethacin and acetic acid induced group (control).
.          The treatment with EASG and CHSG leaves extract of Simarouba glauca has shown a 
decrease in the macroscopic scores for the inflammation. A significant decrease in MPO activity 
was also observed. All these observations support the findings that the EASG and CHSG leaves 
extract of Simarouba glauca was able to offer significant protection in both the models studied.
        Acetic acid-induced colitis and indomethacin-induced enterocolitis simulate two different 
disease conditions, which are ulcerative colitis and Crohn’s disease respectively. On this basis 
we can say that the EASG and CHSG extracts under study may be useful in treating UC as well 
as CD in humans.
            The mechanism of development of disease in indomethacin-induced enterocolitis 
involves role of protective prostaglandins and intestinal pathogens. The extracts  might be active 
due to its anti-inflammatory, cytoprotective and antimicrobial properties. Acetic acid-induced 
colitis involves inflammatory response initiated by the injury caused by acid. It involves 
stimulation of cyclooxygenase and lipooxygenase pathways and generation of inflammatory 
mediators like prostaglandins and leukotrienes. The extracts  may have an effect on synthesis or 
release of these inflammatory mediators.
The prednisolone treatment has shown significant protection in both the animal models under our 
study. The EASG and CHSG leaves extract of Simarouba glauca was found comparable with 
prednisolone.The EASG and CHSG leaves extract of Simarouba glauca at doses 400 and 400 
mg/kg was as good as prednisolone at the doses 10mg/kg for rats. It is possible that the extracts 
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acts by the same mechanism as the prednisolone i.e., by decreasing the number of neutrophils 
and reduction in the synthesis of inflammatory mediators.
The myeloperoxidase assay showed significant increase in MPO activity of indomethacin and 
acetic acid induced control group compared to normal untreated group. The Extracts  treated and 
prednisolone treated group showed significant reduction in MPO activity compared to the control 
group, and from the two extracts CHSG was to be more effective in reducing MPO levels when 
compared to EASG.
      Oxidative stress is the main cause in the pathogenesis of inflammatory bowel disease.The 
activity of SOD is a sensitive index in oxidative damage as it scavenges the superoxide anion to 
form hydrogen peroxide leading to diminish the toxic effects.The catalase is an enzymatic 
antioxidant that decomposes hydrogen peroxide and protects the tissue from highly reactive 
hydrogen peroxide through simultaneous oxidation of reduced glutathione(GSH) to oxidized 
glutathione(GSSH).GSH reacts with free radicals and protects from singlet oxygen,hydroxyl 
radicals and superoxide radical damage.Therefore reduction in the activity of these enzymes may 
result in a number of deleterious effects due to accumulation of superoxide radicals and 
hydrogen peroxide,linked with inflammatory bowel disease.Therefore evaluation of the 
protective effect of CHSG&EASG in rats intestinal oxidative stress parameters and antioxidant 
mechanisms was another objective study.In the present study,data revealed that the efficacy of 
ethylacetate and chloroform  Extract of Simarouba glauca on the level of SOD, CAT, GSH, GPx 
and LPO in experimental animals. In IBD the activity of the SOD, CAT, GSH, and GPx were 
found to be increased in the ethylacetate and chloroform extract of Simarouba glauca in treated 
rats and decrease only in Idomethacin and acetic acid group treated animals. All the SOD, CAT, 
GSH, GPx were significantly altered with the treatment of EASG & CHSG extract of Simarouba 
glauca and prednisolone standard groups when compared with group only indomethacin and 
acetic acid induced animals. In this study the lipid peroxidation and was significantly increased
in control group animal when compared with the group treated with EASG and CHSG as well as 
prednisolone  standard treated group. From the invivo antioxidants studies it was found that 
CHSG extract has more invivo antioxidants activity when compared to EASG extract.
            Histological examination of indomethacin control group showed advanced lesions as 
necrosis of even payers patches and fragmentation of nuclei. The EASG and CHSG extracts 
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treated group showed reduced intensity of lesions without any evidence of necrosis, regeneration 
or inflammatory reaction. Prednisolone treatment showed suppressed inflammatory reaction.
         Histological examination of Acetic acid control group showed massive necrosis of the 
mucosa and submucosa. EASG and CHSG extracts treated group showed mild lesions, 
regeneration and inflammatory reaction. The prednisolone treated group showed suppressed 
inflammatory reaction.Among the two extracts it is evident that the CHSG extract shows more 
anti inflammatory action when compared to EASG extract.
      .
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6. CONCLUSION
Inflammatory bowel disease (IBD) is a chronic inflammatory, idiopathic disorder of 
intestine with unknown etiology. Inflammatory bowel disease is of two different types; 
ulcerative colitis and Crohn’s disease. Ulcerative colitis mainly involves inflammation of colon 
where as Crohn’s disease is an inflammation of gastrointestinal tract from the mouth to the anus. 
Only 10 to 20% of people suffering from IBD have major problem that this disease itself leads to 
colon cancer or bowel cancer. Generation of the free radicals during the progression of the IBD 
has been suggested as an important factor for initiation and progression of cancer. Genetic 
modulation, infective agents, immunological disturbance, smoking, microorganism were found 
to be responsible for mucosal inflammation, hemorrhage and development of ulcers in colon.
Based on the results obtained,it can be concluded that the Ethylacetate and Chloroform 
extract of Simarouba glauca has a protective activity against experimentally induced IBD, due to 
its anti-inflammatory and antioxidant properties. The protective action of this plant may be due 
to the presence of active constituents β-sitosterol , flavanoids and polyphenols.All the Parameters 
of extract treated group animals have shown better results which are comparable with the 
standard prednisolone treated group. Possible mechanism of action may be due to decreasing 
number of neutrophils and reduction in the synthesis of inflammatory mediators like 
myeloperoxidase enzyme.
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